GoAI
Get started
Kohjin Bio Co., Ltd. logo

Kohjin Bio Co., Ltd.

177A.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥845

−¥1.00 · -0.12%

Aug 24, 3:30 PM JST

177A.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
JP

Market position

Day range

Current ¥845

52-week range

Current ¥845

Open
¥846
Previous close
¥846
Volume
1.8K
Market cap
4.32B JPY
50-day average
¥906.24
-6.76% below average
200-day average
¥1,235.57
-31.61% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.89B JPY
P/E (TTM)
34.06×
P/B (TTM)
0.73×
P/S (TTM)
0.92×
EV / EBITDA
7.69×
Earnings yield
4.06%
Free cash flow yield
-4.54%
Dividend yield
1.18%

Profitability & efficiency

Gross margin
35.65%
Operating margin
3.32%
Net margin
2.70%
Return on equity
4.22%
Return on assets
2.82%
Return on invested capital
3.13%

Financial health

Debt / equity
0.31×
Current ratio
1.8×
Altman Z-score
2.27
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends56%38%19%0%Gross margin, FY2022: 51.66%Gross margin, FY2023: 51.74%Gross margin, FY2024: 39.44%Gross margin, FY2025: 45.45%Gross margin, FY2026: 37.60%Operating margin, FY2022: 24.56%Operating margin, FY2023: 26.72%Operating margin, FY2024: 12.51%Operating margin, FY2025: 19.04%Operating margin, FY2026: 6.92%Net margin, FY2022: 14.89%Net margin, FY2023: 17.50%Net margin, FY2024: 8.05%Net margin, FY2025: 15.27%Net margin, FY2026: 5.08%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 51.66%. Gross margin FY2023 51.74%. Gross margin FY2024 39.44%. Gross margin FY2025 45.45%. Gross margin FY2026 37.60%. Operating margin FY2022 24.56%. Operating margin FY2023 26.72%. Operating margin FY2024 12.51%. Operating margin FY2025 19.04%. Operating margin FY2026 6.92%. Net margin FY2022 14.89%. Net margin FY2023 17.50%. Net margin FY2024 8.05%. Net margin FY2025 15.27%. Net margin FY2026 5.08%.

Income trends

Revenue

4.94B JPY-5.13%

Operating income

341.54M JPY-65.54%

Net income

251.02M JPY-68.42%
Income trends across reported periods5.7B JPY3.72B JPY1.74B JPY−244.51M JPYRevenue, FY2022: 3.95B JPYRevenue, FY2023: 4.74B JPYRevenue, FY2024: 4.77B JPYRevenue, FY2025: 5.21B JPYRevenue, FY2026: 4.94B JPYOperating income, FY2022: 969.58M JPYOperating income, FY2023: 1.27B JPYOperating income, FY2024: 596.82M JPYOperating income, FY2025: 991.14M JPYOperating income, FY2026: 341.54M JPYNet income, FY2022: 587.68M JPYNet income, FY2023: 829.79M JPYNet income, FY2024: 384M JPYNet income, FY2025: 794.76M JPYNet income, FY2026: 251.02M JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 3.95B JPY. Revenue FY2023 4.74B JPY. Revenue FY2024 4.77B JPY. Revenue FY2025 5.21B JPY. Revenue FY2026 4.94B JPY. Operating income FY2022 969.58M JPY. Operating income FY2023 1.27B JPY. Operating income FY2024 596.82M JPY. Operating income FY2025 991.14M JPY. Operating income FY2026 341.54M JPY. Net income FY2022 587.68M JPY. Net income FY2023 829.79M JPY. Net income FY2024 384M JPY. Net income FY2025 794.76M JPY. Net income FY2026 251.02M JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue4.94B JPY5.21B JPY4.77B JPY4.74B JPY3.95B JPY
Cost of goods sold3.08B JPY2.84B JPY2.89B JPY2.29B JPY1.91B JPY
Gross profit1.86B JPY2.37B JPY1.88B JPY2.45B JPY2.04B JPY
Selling, general, and administrative1.52B JPY—−1K JPY1.19B JPY1.07B JPY
Operating expenses1.52B JPY1.37B JPY1.28B JPY1.19B JPY1.07B JPY
Interest income4.42M JPY1.93M JPY651K JPY425K JPY273K JPY
Interest expense38.05M JPY30.07M JPY22.87M JPY32.47M JPY38.94M JPY
Depreciation and amortization396.15M JPY360.97M JPY299.63M JPY167.59M JPY179.06M JPY
Operating income341.54M JPY991.14M JPY596.82M JPY1.27B JPY969.58M JPY
Net income251.02M JPY794.76M JPY384M JPY829.79M JPY587.68M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-8.2

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates59.6535.3611.06-13.23Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 22.08, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 47.25, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 54.62, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual 16.1, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 23.43, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 15.18, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual -5.6, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual -8.2, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates1.47B1.29B1.1B917.36MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 1.27B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 1.42B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 1.28B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual 1.22B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 13, 2025: actual 1.29B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 1.29B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 1.15B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 974M JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

DividendUpcoming

Ex-dividend Mar 30, 2027

¥10.00

Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥10.00

Annual

Record Mar 31, 2026 · Payment Jun 29, 2026

Dividend

Ex-dividend Mar 28, 2025

¥24.00

Annual

Record Mar 31, 2025 · Payment Jun 30, 2025

177A.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 177A.T

research.disclaimer